1. Home
  2. MEG vs AURA Comparison

MEG vs AURA Comparison

Compare MEG & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$22.14

Market Cap

930.8M

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.50

Market Cap

772.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
AURA
Founded
2012
2007
Country
United States
United States
Employees
3500
113
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.8M
772.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
MEG
AURA
Price
$22.14
$7.50
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$35.25
$20.00
AVG Volume (30 Days)
266.4K
772.3K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
93.69
N/A
EPS
N/A
N/A
Revenue
$830,538,000.00
N/A
Revenue This Year
$5.41
N/A
Revenue Next Year
$7.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.26
N/A
52 Week Low
$19.38
$4.73
52 Week High
$32.00
$9.54

Technical Indicators

Market Signals
Indicator
MEG
AURA
Relative Strength Index (RSI) 52.09 48.84
Support Level $20.80 $5.94
Resistance Level $23.48 $7.68
Average True Range (ATR) 0.79 0.35
MACD 0.13 -0.08
Stochastic Oscillator 88.92 25.90

Price Performance

Historical Comparison
MEG
AURA

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: